Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-49

I don't really get what's confusing?

After the existing IP agreements are finished - there are no more (of course we hope that's not the case) - and cash burn is $2mil per Q.

That doesn't include Carslbad manufacturing, sales force commission, shipping etc.

It will take $6,000,000 AUD in product sales to cover costs - the actual profit will be much lower as there will be expenses in getting that product to the marketplace.

As it stands:

The Burnett and Hologic deal covers Q2 cash burn.

To cover Q3 & Q4 we need product sales (as above) or the CR funding will be gone.

Is that clearer mate?